×

Concerned about your own or
someone else’s drug use?

Clinical Research Fellowships 2019

Investigating the outcomes of providing specialist neuropsychological assessment to individuals with alcohol or polysubstance use histories attending Alcohol and Other Drug treatment services.

Amount awarded: $140,500.00

Principal Investigator: Dr James Gooden, NCCRED Clinical Research Scholar

Investigating the outcomes of providing specialist neuropsychological assessment to individuals with alcohol or polysubstance use histories attending Alcohol and Other Drug treatment services.

Amount awarded: $140,500.00

Principal Investigator: Dr James Gooden, NCCRED Clinical Research Scholar

Cognitive impairment is common in clients with substance use disorder, with prevalence rates ranging from 30-80% (Bates, Bowden & Barry, 2002), highlighting the importance of cognitive assessment and intervention in addiction settings. Research has shown improved diagnostic accuracy and functional outcomes following neuropsychology consultation across varying neurological disorders (Watt & Crowe, 2018), however, there is limited research exploring the impact of neuropsychology in an addiction setting. Demonstrating the role and value-add of neuropsychology in this context is critical to increasing access to services in order to meet demand.

Preliminary work from our addiction neuropsychology service has identified multiples areas of unmet need, enhanced understanding, and informed our clinical practice within this clinical cohort. In order to extend this work, this study aims to investigate the biopsychosocial factors associated with cognitive impairment in addition to the outcomes of accessing neuropsychological services for individuals with significant alcohol and polysubstance use.

To investigate the first aim we will conduct a retrospective analysis of our clinical database of clients seen for assessment since 2014. To investigate the second aim, we will conduct a prospective outcome study exploring the potential benefits of providing neuropsychological services to this clinical cohort. Baseline measures will be completed immediately prior to the neuropsychology assessment and will include measures of quality of life, alcohol and substance use, self-efficacy, emotional distress and questionnaires regarding the client’s understanding of their cognitive abilities and their presenting concerns. A follow up, approximately eight weeks following the client’s therapeutic feedback appointment will then be conducted to explore any changes within these variables. Outcome measures for the project will also include any new diagnoses conveyed as a result of the assessment, new recommendations for referrals and whether the client is eligible to access new funding or services in addition to changes in the measures administered at baseline.

Dr James Gooden, Clinical Neuropsychologist, NCCRED Clinical Research Scholar

Turning Point (Eastern Health); Monash Addiction Research Centre, Eastern Health Clinical School, Monash University

Dr Catherine Cox, Senior Clinical Neuropsychologist

Turning Point (Eastern Health)

Dr Vanessa Petersen, Clinical Neuropsychologist

Turning Point (Eastern Health)

Ms Georgia Bolt, Clinical Neuropsychologist

Turning Point (Eastern Health)

A/Prof Victoria Manning, Head of Research and Workforce Development

Turning Point (Eastern Health); Monash Addiction Research Centre, Eastern Health Clinical School, Monash University

Dr Shalini Arunogiri, Addiction Psychiatrist

Turning Point (Eastern Health); Monash Addiction Research Centre, Eastern Health Clinical School, Monash University

Publications

Maybe it’s not the meth: Considering biopsychosocial contributors to cognitive impairment in methamphetamine polydrug use

Predictors of cognitive functioning in presentations to a community based specialist addiction neuropsychology service

Gooden, J R., Cox, C. A., Petersen, V., Curtis, A., Sanfilippo, P., Manning, V., Bolt, G. L. Lubman, D. I. (In Press) Predictors of cognitive functioning in presentations to a community based specialist addiction neuropsychology service. Brain Impairment.

Presentations

Gooden, J.R. Predictors of cognitive functioning in presentations to addiction neuropsychology: Are we paying enough attention to modifiable risk factors? Talking Point, Richmond, 2021.

Watch it here

Gooden, J.R. Predictors of cognitive functioning in presentations to addiction neuropsychology: Are we paying enough attention to modifiable risk factors? Talking Point, Richmond, 2021.

Watch it here

Gooden, J R., Cox, C. A., Petersen, V., Curtis, A., Sanfilippo, P., Manning, V., Bolt, G. L. Lubman, D. I. Predictors of cognitive functioning in presentations to a community based specialist addiction neuropsychology service. Oral presentation at the INS, ASSBI, CCN 6th Pacific Rim Conference, Melbourne 2021.

Gooden, J R., Cox, C. A., Petersen, V., Curtis, A., Sanfilippo, P., Manning, V., Bolt, G. L. Lubman, D. I. Predictors of cognitive functioning in presentations to a community based specialist addiction neuropsychology service. Oral presentation at the INS, ASSBI, CCN 6th Pacific Rim Conference, Melbourne 2021.

Gooden, J.R. & Petersen, V. Supporting AOD clients with cognitive impairment: What clinicians needs to know. Comorbidity Guidelines Webinar, 2022.

Watch it here

Gooden, J.R. & Petersen, V. Supporting AOD clients with cognitive impairment: What clinicians needs to know. Comorbidity Guidelines Webinar, 2022.

Watch it here